PofoliaShared via Pofolia

Journal of the International AIDS Society· 2026Q1

Fidelity of Implementation of Oral Pre‐Exposure Prophylaxis for HIV in Public Family Planning Clinics in Kenya: Results From a Stepped‐Wedge Cluster Randomized Trial

Irene Mukui, Sandra Urusaro, John Kinuthia, Daniel N. Matemo et al.

Short summary

Oral HIV pre-exposure prophylaxis (PrEP) integration into Kenyan family planning (FP) clinics was achieved, but fidelity varied across service components, with risk assessment (85.7%) and HIV prevention discussion (100%) high, but counselling (64.3%) and safety assessment (42.9%) lower.

AI-generated from the title and abstract; the full text is not read.

Key points

  • HIV risk behavior assessment occurred in 85.7% of observed PrEP service encounters.
  • HIV prevention strategies were discussed in 100% of encounters.
  • PrEP counseling was discussed in 64.3% of encounters.
  • Medical safety assessment for PrEP occurred in 42.9% of encounters.
  • Providers were respectful and used understandable language in all encounters.

AI-generated from the title and abstract; the full text is not read.

Abstract

INTRODUCTION: Integrating HIV pre-exposure prophylaxis (PrEP) into family planning (FP) services offers a strategic opportunity to reach women at risk of HIV acquisition. We assessed fidelity to core components of oral PrEP delivery in real-world FP clinics in Kenya. METHODS: Data are from the FP Plus Project, a stepped-wedge cluster-randomized trial integrating oral PrEP into 12 public FP clinics in Kisumu, Kenya, where trained FP healthcare providers delivered PrEP services within routine services. Standardized unannounced client actor visits conducted between December 2021 and April 2022, and cross-sectional exit surveys conducted between July 2021 and July 2024 among FP clients were used to evaluate whether the core components of PrEP services were delivered as intended and to assess service quality. Client actors were trained on three case scripts depicting young women in different scenarios: PrEP initiation, PrEP continuation and PrEP during routine FP visits. After each unannounced visit, client actors completed checklists documenting delivery of PrEP services, including behavioural risk assessment, HIV testing, HIV prevention and PrEP counselling, safety assessment, PrEP dispensing and quality-of-care. Data were analysed descriptively. RESULTS: Overall, 28 client actor visits were completed across participating FP clinics; 12 initiation, 12 continuation and 4 integrated FP-PrEP initiation. Providers assessed at least one HIV risk behaviour in 85.7% (24/28) of visits and discussed at least one HIV prevention strategy in all visits (100%, 28/28). At least one PrEP counselling topic was discussed in 64.3% (18/28) of visits, and one medical safety area was assessed in 42.9% (12/28) of visits. Unprompted PrEP promotion was low at 28.6% (8/28) of visits. Completion of individual items within service components varied widely. Providers were respectful, non-judgemental and used easy-to-understand language in all (28/28) client actor encounters. Of 1801 exit interview participants, 99.8% (1797/1801) discussed at least one HIV prevention strategy and 96.5% (1737/1801) expressed trust in the FP providers. CONCLUSIONS: Integration of oral PrEP provision into routine FP clinics was achieved with varied fidelity across service components. While engagement occurred across PrEP service components, gaps remained in completeness of counselling, PrEP promotion and medical safety assessment, highlighting the need for continued provider support and quality improvement. CLINICAL TRIAL NUMBER: NCT04666792.

The authors' abstract, as published at the source. Journal of the International AIDS Society, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Infectious Diseases

Infectious DiseasesMedicine